Back Pain Clinical Trial
Official title:
Validation of a Decision Rule to Limit CT Scanning in Suspected Renal Colic
Computed tomography (CT) scanning is overused, expensive, and causes cancer. CT scan utilization in the U.S. has increased from an estimated 3 million CTs in 1980 to 62 million per year in 2007. From 2000 through 2006, Medicare spending on imaging more than doubled to $13.8 billion with advanced imaging such as CT scanning largely responsible. CT represents only 11% of radiologic examinations but is responsible for two-thirds of the ionizing radiation associated with medical imaging in the U.S. Recent estimates suggest that there will be 12.5 cancer deaths for every 10,000 CT scans. Renal colic is a common, non-life-threatening condition for which CT is overused. As many as 12% of people will have a kidney stone in their lifetime, and more than one million per year will present to the emergency department (ED). CT is now a first line test for renal colic, and is very accurate. However, 98% of kidney stones 5mm or smaller will pass spontaneously, and CT rarely alters management. A decision rule is needed to determine which patients with suspected renal colic require CT. While the signs and symptoms of renal colic have been shown to be predictable, no rule has yet been rigorously derived or validated to guide CT imaging in renal colic. A subset of patients with suspected renal colic may have a more serious diagnosis or a kidney stone that will require intervention; however the investigators maintain that clinical criteria, point of care ultrasound and plain radiography (when appropriate), will provide a more comparatively effective and safer approach by appropriately limiting imaging.
Study Aim: The specific aim of this study is to prospectively validate the previously derived
decision rule for obtaining a Flank Pain Protocol (FPP) CT scan in suspected renal colic.
The investigators will integrate the derived clinical decision rule from the ongoing
retrospective analysis with gestalt clinician pre-test probability, point of care ultrasound,
and plain radiography (when appropriate) to prospectively and observationally test the rule
at two distinct clinical settings. CT results and 90-day follow-up will be used to determine
predefined outcomes.
Study Hypothesis: Prospective observational testing of a clinical decision rule, combined
with point of care ultrasound and plain radiography when appropriate, will categorize >85% of
patients who will require intervention, validating a decision rule to avoid unnecessary CT.
This amendment comes from recent evidence and work at our institution to develop an
"ultra-low dose" CT scan protocol (ULDCT) with an effective radiation dose close to that of a
plain film of the abdomen (KUB), or near 1mSv (compared to 8.5mSv in current practice). While
we expect the ULDCT to be better than a KUB at localizing and characterizing kidney stones,
what is unknown is how the loss in resolution with an ultra-low dose CT protocol might affect
this localization and characterization of stones relative to a regular dose CT (current
protocol), as well as the ability to find alternate diagnoses. Incorporating this additional
imaging study in a subgroup of patients during the observational phase will allow us to
determine test characteristics of the ULDCT that will allow incorporation into the
prospective phase. This will hopefully provide excellent evidence about how to implement an
ultra-low dose CT scan in practice, ultimately leading to a dramatic reduction in radiation
exposure for a large number of patients at Yale and other sites.
We filed an amendment 11-15-2011. This amendment comes from recent evidence and work at our
institution to develop an "ultra-low dose" CT scan protocol (ULDCT) with an effective
radiation dose close to that of a plain film of the abdomen (KUB), or near 1mSv (compared to
8.5mSv in current practice). While we expect the ULDCT to be better than a KUB at localizing
and characterizing kidney stones, what is unknown is how the loss in resolution with an
ultra-low dose CT protocol might affect this localization and characterization of stones
relative to a regular dose CT (current protocol), as well as the ability to find alternate
diagnoses. Incorporating this additional imaging study in a subgroup of patients during the
observational phase will allow us to determine test characteristics of the ULDCT that will
allow incorporation into the prospective phase. This will hopefully provide excellent
evidence about how to implement an ultra-low dose CT scan in practice, ultimately leading to
a dramatic reduction in radiation exposure for a large number of patients at Yale and other
sites.
This amendment comes from recent evidence and work at our institution to develop an
"ultra-low dose" CT scan protocol (ULDCT) with an effective radiation dose close to that of a
plain film of the abdomen (KUB), or near 1mSv (compared to 8.5mSv in current practice). While
we expect the ULDCT to be better than a KUB at localizing and characterizing kidney stones,
what is unknown is how the loss in resolution with an ultra-low dose CT protocol might affect
this localization and characterization of stones relative to a regular dose CT (current
protocol), as well as the ability to find alternate diagnoses. Incorporating this additional
imaging study in a subgroup of patients during the observational phase will allow us to
determine test characteristics of the ULDCT that will allow incorporation into the
prospective phase. This will hopefully provide excellent evidence about how to implement an
ultra-low dose CT scan in practice, ultimately leading to a dramatic reduction in radiation
exposure for a large number of patients at Yale and other sites.
Future Direction: Ultimately the investigators intend to implement the validated decision
rule at both study sites to evaluate further the feasibility, physician acceptance and
comparative effectiveness of our rule. Using standard dissemination techniques and
integration of the rule into the computerized physician order entry (CPOE) system at our
institutions the investigators will determine the actual reduction in the number of FPP CT
scans ordered, clinical outcomes based on 90-day follow up, survey of physician acceptance of
the rule as well as an comparative effective analysis. The investigators will submit an
application at a later date nearing the end of our projected enrollment for this study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05982483 -
Erector Spinae Plane Block vs. Usual Care for ED Patients With Mechanical Back Pain
|
N/A | |
Completed |
NCT04744246 -
Muscle Activity During Load Carriage in ROTC Cadets
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Active, not recruiting |
NCT03680846 -
Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain
|
N/A | |
Completed |
NCT05597189 -
Clinical Study for Palliative/Preventive Treatment of Chronic Back Pain
|
N/A | |
Completed |
NCT05342181 -
Static and Dynamic Core Stability Exercises in Potpartum Back Pain
|
N/A | |
Completed |
NCT02955342 -
Back and Neck Pain in Adolescence
|
||
Completed |
NCT02704845 -
Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain
|
N/A | |
Not yet recruiting |
NCT02536274 -
"Examination of the Impact of a Dynamic Flexion Orthosis (Dynaflex®Ottobock) or of a Back Bandage (Lumbo Sensa®Ottobock) on the Voluntary Activation of the Back Muscles in Patients With Specific Back Pain"
|
N/A | |
Recruiting |
NCT02237105 -
The Effect of Cognitive Behavioral Therapy on the Outcome of Spinal Surgery
|
N/A | |
Enrolling by invitation |
NCT02485795 -
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management
|
N/A | |
Completed |
NCT02609009 -
Back Pain and Spinal Manipulation in Adolescent Scoliosis
|
N/A | |
Terminated |
NCT02239627 -
Epidural Clonidine Versus Corticosteroid for Low Back Pain
|
N/A | |
Completed |
NCT02254694 -
The Influence of High Heeled Shoes on the Sagittal Balance of the Spine and Whole Body
|
N/A | |
Completed |
NCT00986180 -
NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain
|
Phase 3 | |
Completed |
NCT00771758 -
Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
|
Phase 3 | |
Terminated |
NCT00769626 -
Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy
|
Phase 3 | |
Withdrawn |
NCT00231374 -
Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning
|
N/A | |
Completed |
NCT00454064 -
Cognitive-behavioural Treatment of Chronic Back Pain
|
Phase 3 | |
Completed |
NCT00103675 -
Sensor Measurement of Acupuncture Needle Manipulation
|
Phase 1 |